Greg Abel, Berkshire Hathaway's new CEO, is shifting the company's investment strategy toward acquiring whole businesses rather than stocks. With nearly $400 billion in cash, Abel has spent less than $3 billion on stock purchases while acquiring Taylor Morrison for $6.8 billion and completing the OxyChem purchase for $9.7 billion. This approach reflects Abel's preference for long-term operational control over portfolio trading, as he finds greater value in whole companies than in the current richly-valued stock market.
Axe note: Greg Abel is steering Berkshire Hathaway towards buying entire companies, shifting away from stock market plays.